Evaluation of in vitro anti-Trypanosoma cruzi activity of medications benznidazole, amiodarone hydrochloride, and their combination
Abstract INTRODUCTION: Approximately seven to eight million people worldwide have Chagas disease. In Brazil, benznidazole is the most commonly used active drug against Trypanosoma cruzi; however, its efficacy is limited, and side effects are frequent. Recent studies suggest that amiodarone may be b...
| Váldodahkkit: | , , , , |
|---|---|
| Materiálatiipa: | Artihkal |
| Giella: | English |
| Almmustuhtton: |
Sociedade Brasileira de Medicina Tropical (SBMT)
|
| Ráidu: | Revista da Sociedade Brasileira de Medicina Tropical |
| Fáttát: | |
| Liŋkkat: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822018000100052&lng=en&tlng=en |